• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Hereditary Central Nervous System Demyelinating Diseases

Hereditary Central Nervous System Demyelinating Diseases - 20 Studies Found

Completed : Imaging Study of the White Matter Lesions in Children With Metachromatic Leucodystrophy
: Late Infantile Metachromatic Leukodystrophy
: 2011-03-09
: Other: High-field MRI (3 Teslas)

Completed : Efficacy METAZYM for the Treatment Metachromatic Leukodystrophy Treated With Hematopoietic Stem Cell Transplantation
: Metachromatic Leukodystrophy
: 2011-02-23
: Drug: rhARSA intravenous infusion 100U/kg every other week for 18 months
Withdrawn : An Observational Study of Pediatric Subjects With Globoid Cell Leukodystrophy (GLD)
: Leukodystrophy, Globoid Cell
: 2010-03-24
Completed : Study of Human Central Nervous System (CNS) Stem Cells Transplantation in Pelizaeus-Merzbacher Disease (PMD) Subjects
: Pelizaeus-Merzbacher Disease
: 2009-10-28
: Biological: HuCNS-SC cells intracerebral transplantation
Completed : The Natural History of Infantile Globoid Cell Leukodystrophy
: Infantile Globoid Cell Leukodystrophy
: 2009-09-23
Active, not recruiting : Diffusion Tensor Imaging (DTI) in Infants With Krabbe Disease
: Krabbe Disease
: 2008-11-07
Completed : Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy
: Metachromatic Leukodystrophy
: 2008-05-21
: Drug: Warfarin Oral administration (QD), variable dosage: patients will undergo blood test for PT/INR at
Terminated : Open-Label Extension Study of Recombinant Human Arylsulfatase A (HGT-1111) in Late Infantile MLD
: Late Infantile Metachromatic Leukodystrophy
: 2008-05-19
: Drug: HGT-1111 Patients currently dosed with 100 U/kg or 200 U/kg will continue this treatment. Patients
Active, not recruiting : The Natural History of Metachromatic Leukodystrophy
: Metachromatic Leukodystrophy
: 2008-03-11
Completed : Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)
: Late Infantile Metachromatic Leukodystrophy
: 2008-02-29
: Biological: Recombinant human Arylsulfatase A (rhASA) intravenous infusion, every other week for 26 week
<<< Previous
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.